GGrantIndex
← Leaderboards

Xingxing Zang

Albert Einstein College Of Medicine

$11,384,072
Attributed
$11,384,072
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.5M · FY200825
$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,384,072 · 4

By mechanism

R01$8,801,582 · 3
DP2$2,582,490 · 1

Top collaborators

No co-investigators on record.

Most similar at Albert Einstein College Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Cd80 Gene

Research focus

Cd80 GeneImmuneFamilyMemberCd28 GenePathway InteractionsOverexpressionCellsProgramsReceptorMissionInnovationTranslatingT-LymphocyteMouse ModelCell PhysiologyInsightMalignant NeoplasmsClinical ResearchPancreasImmunotherapyMonoclonal AntibodiesPublic HealthVtcn1 Gene

Grant awards (34)

A New Immune Checkpoint Pathway in Human Bladder Cancer$545,478
R01 · FY2025 · CA · contact PI
The B7x pathways in the tumor microenvironment$399,000
R01 · FY2025 · CA · contact PI
A New Immune Checkpoint Pathway in Human Bladder Cancer$101,835
R01 · FY2025 · CA · contact PI
A New Immune Checkpoint Pathway in Human Bladder Cancer$518,205
R01 · FY2024 · CA · contact PI
The B7x pathways in the tumor microenvironment$379,050
R01 · FY2024 · CA · contact PI
The B7x pathways in the tumor microenvironment$378,000
R01 · FY2024 · CA · contact PI
A New Immune Checkpoint Pathway in Human Bladder Cancer$96,743
R01 · FY2024 · CA · contact PI
The B7x pathways in the tumor microenvironment$85,226
R01 · FY2024 · CA · contact PI
A New Immune Checkpoint Pathway in Human Bladder Cancer$545,478
R01 · FY2023 · CA · contact PI
The B7x pathways in the tumor microenvironment$391,020
R01 · FY2023 · CA · contact PI
The B7x pathways in the tumor microenvironment$370,440
R01 · FY2023 · CA · contact PI
The B7x pathways in the tumor microenvironment$80,741
R01 · FY2023 · CA · contact PI
A new immune checkpoint pathway in human bladder cancer$23,779
R01 · FY2023 · CA · contact PI
The B7x pathways in the tumor microenvironment$391,020
R01 · FY2022 · CA · contact PI
Tumor-expressed immune checkpoint B7x-mediated resistance to anti-CTLA-4 therapy.$378,000
R01 · FY2022 · CA · contact PI
NCI Diversity Supplement$48,216
R01 · FY2022 · CA · contact PI
The B7x pathways in the tumor microenvironment$398,901
R01 · FY2021 · CA · contact PI
Mechanisms and Therapies of B7x and B7-H3 in T1D$375,750
R01 · FY2019 · DK · contact PI
The B7x pathway in the tumor microenvironment$277,851
R01 · FY2018 · CA · contact PI
Mechanisms and Therapies of B7x and B7-H3 in T1D$209,503
R01 · FY2018 · DK · contact PI
Mechanisms and Therapies of B7x and B7-H3 in T1D$166,247
R01 · FY2018 · DK · contact PI
The B7x pathway in the tumor microenvironment$68,674
R01 · FY2018 · CA · contact PI
Mechanisms and Therapies of B7x and B7-H3 in T1D$375,750
R01 · FY2017 · DK · contact PI
The B7x pathway in the tumor microenvironment$346,525
R01 · FY2017 · CA · contact PI
Mechanisms and Therapies of B7x and B7-H3 in T1D$375,750
R01 · FY2016 · DK · contact PI
The B7x pathway in the tumor microenvironment$346,525
R01 · FY2016 · CA · contact PI
Mechanisms and therapies of B7x and B7-H3 in T1D$375,750
R01 · FY2015 · DK · contact PI
The B7x pathway in the tumor microenvironment$235,486
R01 · FY2015 · CA · contact PI
The B7x pathway in the tumor microenvironment$111,039
R01 · FY2015 · CA · contact PI
The B7x pathway in the tumor microenvironment$346,525
R01 · FY2014 · CA · contact PI
The B7x pathway in the tumor microenvironment$59,075
R01 · FY2014 · CA · contact PI
New T Cell Coinhibitory Pathway and Type 1 Diabetes$90,000
DP2 · FY2010 · DK · contact PI
New T Cell Coinhibitory Pathway and Type 1 Diabetes$2,490
DP2 · FY2010 · DK · contact PI
New T Cell Coinhibitory Pathway and Type 1 Diabetes$2,490,000
DP2 · FY2008 · DK · contact PI